• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MOLECULAR, INC. PROBECHEK UROVYSION CONTROL SLIDE; TEST, FLUORESCENCE IN SITU HYBRIDIZATION (FISH), FOR BLADDER CANCER DETECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MOLECULAR, INC. PROBECHEK UROVYSION CONTROL SLIDE; TEST, FLUORESCENCE IN SITU HYBRIDIZATION (FISH), FOR BLADDER CANCER DETECTION Back to Search Results
Model Number 02J27-011
Device Problem Device Damaged Prior to Use (2284)
Patient Problem No Patient Involvement (2645)
Event Date 01/29/2020
Event Type  malfunction  
Manufacturer Narrative
Elevated complaint investigation has been initiated.
 
Event Description
Customer reports receipt of broken probechek urovysion control slides.There was no patient involved as the wholesaler discovered it on (b)(6) 2020, and contacted his sales representative.There were no injuries associated with this observation.This incident is being reported to fda because the incident occurred in (b)(6) using probechek urovysion control slides, list number 02j27-11, which is also us fda approved.
 
Manufacturer Narrative
Investigation into this complaint included an evaluation of the quality data review (device history record (dhr) review and capa review), complaint history review, and inspection of abbott molecular (am) retains from the same lot of material in question.The results of the investigation are summarized as follows: the device history record / batch record review identified no errors or issues.The products under investigation met inspection requirements at the time of release.A process review indicated slides are inspected at regular intervals for damage in the manufacturing process and that slides are packed and shipped sufficiently to minimize damage.Capa / non-conformance review identified no related non-conformance or capa records within the last two years.Retain / file sample evaluation: a visual inspection using am retain sample from the same lot of material in question was performed to determine if products had any visually identifiable damage.No damage was identified.Complaint history review identified the complaint addressed here as the only ticket reporting broken/damaged slides in the last year.No additional complaints were identified.Based on the results of the investigation elements, a product or systemic deficiency for probechek urovysion control slides: part# 30-505070/lot# 496330 (kit: probechek urovysion bladder cancer kit control slides: part# 30-805070 (list# 02j27-011)/lot# 497909) has not been identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROBECHEK UROVYSION CONTROL SLIDE
Type of Device
TEST, FLUORESCENCE IN SITU HYBRIDIZATION (FISH), FOR BLADDER CANCER DETECTION
Manufacturer (Section D)
ABBOTT MOLECULAR, INC.
1300 e. touhy ave.
des plaines, il
MDR Report Key9747843
MDR Text Key191918381
Report Number3005248192-2020-00002
Device Sequence Number1
Product Code NSD
UDI-Device Identifier00884999002128
UDI-Public00884999002128
Combination Product (y/n)N
PMA/PMN Number
P030052
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 04/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/24/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date05/13/2020
Device Model Number02J27-011
Device Catalogue Number02J27-11
Device Lot Number497909
Was Device Available for Evaluation? Yes
Date Manufacturer Received03/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-